slotkoers
Shenzhen S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
17,75
CNY
|
+1,66%
|
|
+3,98%
|
-7,07%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
8.159
|
14.737
|
11.674
|
9.611
|
11.206
|
10.414
|
-
|
-
|
Bedrijfswaarde
1 |
8.159
|
14.737
|
11.674
|
9.611
|
11.206
|
10.414
|
10.414
|
10.414
|
K/w-verhouding
|
24,6
x
|
119
x
|
28,7
x
|
24,4
x
|
21,7
x
|
16,9
x
|
13,5
x
|
11,2
x
|
Dividendrendement
|
-
|
-
|
-
|
0,61%
|
-
|
1,35%
|
1,63%
|
1,97%
|
Marktkapitalisatie/omzet
|
9,7
x
|
17,4
x
|
7,3
x
|
6,36
x
|
6,43
x
|
5,08
x
|
4,29
x
|
3,62
x
|
Bedrijfswaarde/omzet
|
9,7
x
|
17,4
x
|
7,3
x
|
6,36
x
|
6,43
x
|
5,08
x
|
4,29
x
|
3,62
x
|
Bedrijfswaarde/EBITDA
|
-
|
79.754.215
x
|
-
|
13.523.933
x
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
4,61
x
|
4,06
x
|
3,12
x
|
3,02
x
|
2,47
x
|
2,15
x
|
1,85
x
|
Aantal aandelen (in duizenden)
|
501.788
|
588.997
|
588.984
|
587.124
|
586.727
|
586.728
|
-
|
-
|
Referentieprijs
2 |
16,26
|
25,02
|
19,82
|
16,37
|
19,10
|
17,75
|
17,75
|
17,75
|
Datum van publicatie
|
28/02/20
|
25/03/21
|
26/04/22
|
19/04/23
|
29/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
840,9
|
848,1
|
1.599
|
1.511
|
1.742
|
2.052
|
2.429
|
2.876
|
EBITDA
|
-
|
184,8
|
-
|
710,7
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
153
|
535,9
|
455,5
|
593,9
|
709
|
874,5
|
1.066
|
Operationele Marge
|
-
|
18,05%
|
33,5%
|
30,15%
|
34,1%
|
34,55%
|
36%
|
37,05%
|
Resultaat voor belastingen (EBT)
1 |
-
|
136,9
|
537
|
449,4
|
593,6
|
709
|
874
|
1.066
|
Nettowinst (verlies)
1 |
-
|
112,3
|
405,7
|
389,1
|
523,7
|
618,4
|
769,5
|
938
|
Nettomarge
|
-
|
13,24%
|
25,36%
|
25,76%
|
30,07%
|
30,14%
|
31,68%
|
32,61%
|
WPA
2 |
0,6600
|
0,2100
|
0,6900
|
0,6700
|
0,8800
|
1,050
|
1,310
|
1,590
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
0,1000
|
-
|
0,2400
|
0,2900
|
0,3500
|
Datum van publicatie
|
28/02/20
|
25/03/21
|
26/04/22
|
19/04/23
|
29/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
4,46%
|
12,1%
|
12,7%
|
14,9%
|
15%
|
16,2%
|
16,9%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
8,71%
|
-
|
10,3%
|
10,9%
|
11,5%
|
Totale activa
1 |
-
|
-
|
-
|
4.466
|
-
|
6.004
|
7.059
|
8.157
|
Nettoactief per aandeel
2 |
-
|
5,430
|
4,880
|
5,250
|
6,330
|
7,180
|
8,270
|
9,620
|
Cashflow per aandeel
2 |
-
|
0,2100
|
0,5800
|
0,6700
|
0,9900
|
0,6700
|
1,140
|
1,340
|
Capex
1 |
-
|
16,9
|
65
|
96,5
|
147
|
126
|
136
|
151
|
Capex/omzet
|
-
|
1,99%
|
4,06%
|
6,39%
|
8,44%
|
6,14%
|
5,6%
|
5,25%
|
Datum van publicatie
|
28/02/20
|
25/03/21
|
26/04/22
|
19/04/23
|
29/03/24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -7,07% | 1,44 mld. | | +0,89% | 12,8 mld. | | -10,29% | 7,61 mld. | | +1,78% | 5,41 mld. | | -1,16% | 4,51 mld. | | +5,74% | 4,49 mld. | | -50,70% | 3,29 mld. | | +12,21% | 2,73 mld. | | -16,13% | 2,02 mld. | | -11,50% | 1,73 mld. |
Diagnostische en teststoffen
|